SMN1 and Hepatic fibrosis: Prominent reduction in several fibrogenic genes and proteins was seen in KPA-treated DIAMOND mice, including reduction of SMA, MMPs, collagens, and TGF-β, a critical mediator of hepatic fibrosis (Figure 8, G and H, and Supplemental Figure 11, B–G).